{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:04:30Z","timestamp":1793703870883,"version":"4.5.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":2543,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.rmed.2005.11.020","type":"journal-article","created":{"date-parts":[[2006,1,19]],"date-time":"2006-01-19T14:07:22Z","timestamp":1137679642000},"page":"1307-1317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":292,"title":["Systemic side effects of inhaled corticosteroids in patients with asthma"],"prefix":"10.1016","volume":"100","author":[{"given":"Ronald","family":"Dahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.rmed.2005.11.020_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00003088-200039001-00003","article-title":"Systemic exposure to fluticasone propionate administered via metered-dose inhaler containing chlorofluorocarbon or hydrofluoroalkane propellant","volume":"39","author":"Mackie","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.rmed.2005.11.020_bib2","unstructured":"National Institutes of Health. Global initiative for asthma: global strategy for asthma management and prevention. 2004. Available from: http:\/\/www.ginasthma.com\/Guidelineitem.asp??l1=2&l2=1&omt; d=60. Accessed October 11, 2005."},{"key":"10.1016\/j.rmed.2005.11.020_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaci.2003.10.041","article-title":"Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation","volume":"113","author":"Miranda","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 2","key":"10.1016\/j.rmed.2005.11.020_bib4","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1136\/thorax.55.suppl_2.S57","article-title":"Chronic bronchial asthma from challenge to treatment: epidemiology and social impact","volume":"55","author":"Neri","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2005.11.020_bib5","unstructured":"Masoli M, Fabian D, Holt S, Beasley R. Global burden of asthma. 2004. http:\/\/www.ginasthma.com\/ReportItem.asp?l1=2&l2=2. Accessed: October 25, 2005."},{"key":"10.1016\/j.rmed.2005.11.020_bib6","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1164\/rccm.2107057","article-title":"The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines","volume":"166","author":"Fuhlbrigge","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2005.11.020_bib7","unstructured":"American Lung Association. Trends in asthma morbidity and mortality, January 2003. Table 13: economic cost of asthma, direct medical and indirect expenditures, US 2002. http:\/\/www.lungusa.org\/site\/apps\/s\/content.asp?c=dvLUK9O0E&b=34706&ct=67648. Accessed October 11, 2005."},{"key":"10.1016\/j.rmed.2005.11.020_bib8","unstructured":"National Institutes of Health: National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program Expert Panel report 2. Clinical practice guidelines: guidelines for the diagnosis and management of asthma. NIH publication no. 97-4051. Bethesda, Maryland: National Institutes of Health\/National Heart, Lung, and Blood Institute; 1997."},{"key":"10.1016\/j.rmed.2005.11.020_bib9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1067\/mai.2001.117880","article-title":"Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma","volume":"108","author":"Busse","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmed.2005.11.020_bib10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1378\/chest.115.1.210","article-title":"The 1997 asthma management guidelines and therapeutic issues relating to the treatment of asthma","volume":"115","author":"Georgitis","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2005.11.020_bib11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0002-9343(99)80404-5","article-title":"Adverse effects of inhaled corticosteroids","volume":"98","author":"Hanania","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.rmed.2005.11.020_bib12","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1056\/NEJM200008033430504","article-title":"Low-dose inhaled corticosteroids and the prevention of death from asthma","volume":"343","author":"Suissa","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmed.2005.11.020_bib13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0091-6749(03)01870-0","article-title":"Potential adverse effects of the inhaled corticosteroids","volume":"112","author":"Kelly","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmed.2005.11.020_bib14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0163-7258(99)00019-4","article-title":"Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effects","volume":"83","author":"Cave","year":"1999","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.rmed.2005.11.020_bib15","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1164\/ajrccm.157.3.157315","article-title":"Efficacy and safety of inhaled corticosteroids. New developments","volume":"157","author":"Barnes","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2005.11.020_bib16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2165\/00003088-200443060-00001","article-title":"Spacer devices for metered dose inhalers","volume":"43","author":"Newman","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.rmed.2005.11.020_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/0091270003260334","article-title":"Risk-benefit value of inhaled glucocorticoids: a pharmacokinetic\/pharmacodynamic perspective","volume":"44","author":"Rohatagi","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.rmed.2005.11.020_bib18","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1378\/chest.124.6.2329","volume":"124","author":"Leone","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2005.11.020_bib19","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archinte.159.9.941","article-title":"Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis","volume":"159","author":"Lipworth","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rmed.2005.11.020_bib20","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJM199610173351607","article-title":"Adrenal insufficiency","volume":"335","author":"Oelkers","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmed.2005.11.020_bib21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/adc.87.6.457","article-title":"Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom","volume":"87","author":"Todd","year":"2002","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.rmed.2005.11.020_bib22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2125.1994.tb04394.x","article-title":"A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects","volume":"38","author":"Grove","year":"1994","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rmed.2005.11.020_bib23","first-page":"1243","article-title":"Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids","volume":"80","author":"Broide","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rmed.2005.11.020_bib24","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/thx.51.3.262","article-title":"Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients","volume":"51","author":"Clark","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2005.11.020_bib25","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1164\/ajrccm.162.6.9912072","article-title":"Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function","volume":"162","author":"Nielsen","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2005.11.020_bib26","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1164\/rccm.2105013","article-title":"Systemic effect comparisons of six inhaled corticosteroid preparations","volume":"165","author":"Martin","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2005.11.020_bib27","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1398-9995.2004.00750.x","article-title":"Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma","volume":"60","author":"Chapman","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2005.11.020_bib28","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.pupt.2005.01.004","article-title":"Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5\u2032 monophosphate in asthmatic patients","volume":"18","author":"Derom","year":"2005","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.rmed.2005.11.020_bib29","unstructured":"Hansel TT, Benezet O, Kaf\u00e9 H, et al. Ciclesonide once daily is comparable with budesonide twice daily in adult patients with asthma. Clin Ther, in press."},{"key":"10.1016\/j.rmed.2005.11.020_bib30","unstructured":"Pedersen S, Garcia MLG, Manjra A, Theron I, Engelst\u00e4tter R. A comparative study of inhaled ciclesonide 160\u03bcg\/day and fluticasone propionate 176\u03bcg\/day in children with asthma. Pediatr Pulmonol, in press."},{"key":"10.1016\/j.rmed.2005.11.020_bib31","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2125.1994.tb04393.x","article-title":"An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers","volume":"38","author":"Grahnen","year":"1994","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rmed.2005.11.020_bib32","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/j.1552-4604.1997.tb04357.x","article-title":"Dependency of cortisol suppression on the administration time of inhaled corticosteroids [published erratum appears in J Clin Pharmacol 1997;37:1000]","volume":"37","author":"Meibohm","year":"1997","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.rmed.2005.11.020_bib33","series-title":"New drugs for asthma, allergy and COPD","first-page":"91","article-title":"Ciclesonide: an on-site-activated steroid","author":"Dietzel","year":"2001"},{"key":"10.1016\/j.rmed.2005.11.020_bib34","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1210\/jcem.87.5.8447","article-title":"Circadian rhythm of serum cortisol after repeated inhalation of the new topical steroid ciclesonide","volume":"87","author":"Weinbrenner","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rmed.2005.11.020_bib35","first-page":"A767","article-title":"Management of moderate to severe bronchial asthma by ciclesonide: a 12-week trial [abstract]","volume":"165","author":"O\u2019Connor","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 38","key":"10.1016\/j.rmed.2005.11.020_bib36","first-page":"406s","article-title":"Treatment of moderate to severe asthma with ciclesonide: a long-term investigation over 52 weeks","volume":"20","author":"O\u2019Connor","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2005.11.020_bib37","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2165\/00128072-200305070-00005","article-title":"Safety of the newer inhaled corticosteroids in childhood asthma","volume":"5","author":"Randell","year":"2003","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.rmed.2005.11.020_bib38","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2165\/00128072-200305060-00001","article-title":"Inhaled corticosteroids in childhood asthma: long-term effects on growth and adrenocortical function","volume":"5","author":"Salvatoni","year":"2003","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.rmed.2005.11.020_bib39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF00280045","article-title":"Assessment of the systemic effects of inhaled glucocorticosteroids: the influence of blood sampling technique and frequency on plasma cortisol and leucocytes","volume":"39","author":"Jennings","year":"1990","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.rmed.2005.11.020_bib40","series-title":"Bronchial asthma: mechanisms and therapeutics","first-page":"818","article-title":"Aerosol corticosteroids","author":"Toogood","year":"1999"},{"key":"10.1016\/j.rmed.2005.11.020_bib41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2222.1990.tb02659.x","article-title":"The effect of an inhaled steroid on the hypothalamic\u2013pituitary\u2013adrenal axis\u2014which tests should be used?","volume":"20","author":"Holt","year":"1990","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.rmed.2005.11.020_bib42","first-page":"838","article-title":"Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo\u2013pituitary\u2013adrenal axis in patients with pituitary disease","volume":"84","author":"Abdu","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rmed.2005.11.020_bib43","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1542\/peds.109.SE1.373","article-title":"Inhaled corticosteroid therapy for asthma in preschool children: growth issues","volume":"109","author":"Allen","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.rmed.2005.11.020_bib44","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1203\/00006450-199701000-00007","article-title":"Knemometry, urine cortisol excretion, and measures of the insulin-like growth factor axis and collagen turnover in children treated with inhaled glucocorticosteroids","volume":"41","author":"Wolthers","year":"1997","journal-title":"Pediatr Res"},{"key":"10.1016\/j.rmed.2005.11.020_bib45","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1183\/09031936.97.10071507","article-title":"Short-term knemometry and urine cortisol excretion in children treated with fluticasone propionate and budesonide: a dose response study","volume":"10","author":"Agertoft","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2005.11.020_bib46","doi-asserted-by":"crossref","first-page":"E40","DOI":"10.1542\/peds.109.3.e40","article-title":"Systemic activity of inhaled steroids in 1- to 3-year-old children with asthma","volume":"109","author":"Anhoj","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.rmed.2005.11.020_bib47","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jaci.2005.01.066","article-title":"Short-term lower-leg growth rate and urine cortisol excretion in children treated with ciclesonide","volume":"115","author":"Agertoft","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmed.2005.11.020_bib48","first-page":"1054","article-title":"The Childhood Asthma Management Program Research Group","volume":"343","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmed.2005.11.020_bib49","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0091-6749(97)70072-1","article-title":"Attained adult height after childhood asthma: effect of glucocorticoid therapy","volume":"99","author":"Silverstein","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmed.2005.11.020_bib50","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1056\/NEJM200010123431502","article-title":"Effect of long-term treatment with inhaled budesonide on adult height in children with asthma","volume":"343","author":"Agertoft","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmed.2005.11.020_bib51","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1183\/09031936.01.17202870","article-title":"Inhaled corticosteroids reduce growth. Or do they?","volume":"17","author":"Brand","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2005.11.020_bib52","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/(SICI)1099-0496(200003)29:3<188::AID-PPUL6>3.0.CO;2-K","article-title":"Effects of high-dose inhaled corticosteroids on bone metabolism in prepubertal children with asthma","volume":"29","author":"Allen","year":"2000","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.rmed.2005.11.020_bib53","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ppul.1950200311","article-title":"Cross-sectional study of bone density in asthmatic children","volume":"20","author":"Hopp","year":"1995","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.rmed.2005.11.020_bib54","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s001980050085","article-title":"Effect of inhaled corticosteroids on bone mineral density in childhood asthma: comparison of fluticasone propionate with beclomethasone dipropionate","volume":"8","author":"Gregson","year":"1998","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.rmed.2005.11.020_bib55","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2105\/AJPH.85.12.1693","article-title":"Inhaled and oral corticosteroids: their effects on bone mineral density in older adults","volume":"85","author":"Marystone","year":"1995","journal-title":"Am J Public Health"},{"key":"10.1016\/j.rmed.2005.11.020_bib56","unstructured":"ASMANEX\u00ae TWISTHALER\u00ae 200 mcg [package insert]. Kenilworth, NJ: Schering Corp.; 2003."},{"key":"10.1016\/j.rmed.2005.11.020_bib57","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/8756-3282(94)90309-3","article-title":"Bone mineral density in asthmatic women on high-dose inhaled beclomethasone dipropionate","volume":"15","author":"Herrala","year":"1994","journal-title":"Bone"},{"key":"10.1016\/j.rmed.2005.11.020_bib58","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/thx.47.6.414","article-title":"Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids","volume":"47","author":"Packe","year":"1992","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2005.11.020_bib59","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(00)02138-3","article-title":"Inhaled corticosteroid use and bone-mineral density in patients with asthma","volume":"355","author":"Wong","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2005.11.020_bib60","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0091-6749(93)90263-F","article-title":"Association of ocular cataracts with inhaled and oral steroid therapy during long-term treatment of asthma","volume":"91","author":"Toogood","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmed.2005.11.020_bib61","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM199707033370102","article-title":"Use of inhaled corticosteroids and the risk of cataracts","volume":"337","author":"Cumming","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmed.2005.11.020_bib62","first-page":"120","article-title":"Inhaled steroids: effect on intraocular pressure in patients without glaucoma","volume":"31","author":"Samiy","year":"1996","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.rmed.2005.11.020_bib63","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.1997.03540330044033","article-title":"Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma","volume":"277","author":"Garbe","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.rmed.2005.11.020_bib64","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1136\/bmj.300.6739.1548","article-title":"Purpura and dermal thinning associated with high dose inhaled corticosteroids","volume":"300","author":"Capewell","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.rmed.2005.11.020_bib65","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1183\/09031936.93.05091068","article-title":"Easy bruising as a side-effect of inhaled corticosteroids","volume":"5","author":"Mak","year":"1992","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2005.11.020_bib66","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1164\/ajrccm.153.3.8630563","article-title":"Effects of an inhaled steroid (budesonide) on skin collagen synthesis of asthma patients in vivo","volume":"153","author":"Autio","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2005.11.020_bib67","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1183\/09031936.96.09020226","article-title":"Skin bruising in asthmatic subjects treated with high doses of inhaled steroids: frequency and association with adrenal function","volume":"9","author":"Roy","year":"1996","journal-title":"Eur Respir J"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461110500510X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461110500510X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:18:11Z","timestamp":1760609891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095461110500510X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":67,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S095461110500510X"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2005.11.020","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic side effects of inhaled corticosteroids in patients with asthma","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2005.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}